A non-interventional, post-authorization safety study (PASS) to evaluate long-term safety of anakinra (Kineret®) in patients with systemic juvenile idiopathic arthritis

26/08/2019
14/03/2024
EU PAS number:
EUPAS28378
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Sobi.ANAKIN-302 Clinical Study Protocol FINAL version 1 13 Mar 2019_Redacted

English (197.21 KB - PDF) View document
Study results
Study results

Sobi.ANAKIN-302 Clinical Study Report FINAL version 15 Nov 2019_Redacted

English (984.26 KB - PDF) View document
Study report
Other information